-+ 0.00%
-+ 0.00%
-+ 0.00%

*Candel Therapeutics: Submission of BLA for CAN-2409 in Prostate Cancer Is Expected in 4Q 2026 >CADL

Dow Jones·11/13/2025 13:27:00

Please log in to view news